Logo image of CGBD

CARLYLE SECURED LENDING INC (CGBD) Stock Fundamental Analysis

NASDAQ:CGBD - Nasdaq - US8722801029 - Common Stock - Currency: USD

13.71  +0.01 (+0.07%)

After market: 13.98 +0.27 (+1.97%)

Fundamental Rating

5

Overall CGBD gets a fundamental rating of 5 out of 10. We evaluated CGBD against 237 industry peers in the Capital Markets industry. CGBD has an average financial health and profitability rating. CGBD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGBD had positive earnings in the past year.
In the past year CGBD had a positive cash flow from operations.
In the past 5 years CGBD has always been profitable.
In the past 5 years CGBD always reported a positive cash flow from operatings.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

CGBD's Return On Assets of 4.41% is fine compared to the rest of the industry. CGBD outperforms 64.98% of its industry peers.
The Return On Equity of CGBD (9.39%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 4.43%, CGBD perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGBD is below the industry average of 7.89%.
The 3 year average ROIC (4.38%) for CGBD is below the current ROIC(4.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.41%
ROE 9.39%
ROIC 4.43%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.36%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CGBD's Profit Margin of 36.54% is amongst the best of the industry. CGBD outperforms 81.86% of its industry peers.
In the last couple of years the Profit Margin of CGBD has grown nicely.
Looking at the Operating Margin, with a value of 45.14%, CGBD is in the better half of the industry, outperforming 78.90% of the companies in the same industry.
In the last couple of years the Operating Margin of CGBD has remained more or less at the same level.
Looking at the Gross Margin, with a value of 48.37%, CGBD is in line with its industry, outperforming 54.01% of the companies in the same industry.
CGBD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 45.14%
PM (TTM) 36.54%
GM 48.37%
OM growth 3Y-3.83%
OM growth 5Y-1.49%
PM growth 3Y-26.4%
PM growth 5Y5.7%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The number of shares outstanding for CGBD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CGBD has less shares outstanding
The debt/assets ratio for CGBD has been reduced compared to a year ago.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CGBD has an Altman-Z score of 0.81. This is a bad value and indicates that CGBD is not financially healthy and even has some risk of bankruptcy.
CGBD has a Altman-Z score (0.81) which is in line with its industry peers.
The Debt to FCF ratio of CGBD is 9.24, which is on the high side as it means it would take CGBD, 9.24 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.24, CGBD perfoms like the industry average, outperforming 56.54% of the companies in the same industry.
CGBD has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CGBD (1.06) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 9.24
Altman-Z 0.81
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CGBD has a Current Ratio of 2.28. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.28, CGBD is in the better half of the industry, outperforming 74.68% of the companies in the same industry.
A Quick Ratio of 2.28 indicates that CGBD has no problem at all paying its short term obligations.
The Quick ratio of CGBD (2.28) is better than 74.68% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.28
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

CGBD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.74%.
The Earnings Per Share has been growing slightly by 2.24% on average over the past years.
CGBD shows a decrease in Revenue. In the last year, the revenue decreased by -8.02%.
Measured over the past years, CGBD shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)-11.74%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)-8.02%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%-12.67%

3.2 Future

The Earnings Per Share is expected to decrease by -5.59% on average over the next years.
Based on estimates for the next years, CGBD will show a small growth in Revenue. The Revenue will grow by 6.47% on average per year.
EPS Next Y-18.46%
EPS Next 2Y-9.02%
EPS Next 3Y-5.59%
EPS Next 5YN/A
Revenue Next Year12.63%
Revenue Next 2Y9.25%
Revenue Next 3Y6.47%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.29, which indicates a rather cheap valuation of CGBD.
87.34% of the companies in the same industry are more expensive than CGBD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.24. CGBD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.28, the valuation of CGBD can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGBD indicates a rather cheap valuation: CGBD is cheaper than 84.39% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.42. CGBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.29
Fwd PE 8.28
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CGBD is valued a bit cheaper than 76.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.61
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CGBD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CGBD's earnings are expected to decrease with -5.59% in the coming years.
PEG (NY)N/A
PEG (5Y)3.25
EPS Next 2Y-9.02%
EPS Next 3Y-5.59%

5

5. Dividend

5.1 Amount

CGBD has a Yearly Dividend Yield of 7.95%, which is a nice return.
Compared to an average industry Dividend Yield of 8.25, CGBD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.95%

5.2 History

The dividend of CGBD has a limited annual growth rate of 1.07%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.07%
Div Incr Years4
Div Non Decr Years4
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

112.94% of the earnings are spent on dividend by CGBD. This is not a sustainable payout ratio.
The Dividend Rate of CGBD has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP112.94%
EPS Next 2Y-9.02%
EPS Next 3Y-5.59%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (8/4/2025, 8:00:00 PM)

After market: 13.98 +0.27 (+1.97%)

13.71

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners26.28%
Inst Owner Change16.16%
Ins Owners0.43%
Ins Owner Change14.09%
Market Cap999.46M
Analysts46
Price Target14.28 (4.16%)
Short Float %0.67%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 7.95%
Yearly Dividend1.88
Dividend Growth(5Y)1.07%
DP112.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date06-30 2025-06-30 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.11%
Min EPS beat(2)-0.5%
Max EPS beat(2)4.72%
EPS beat(4)2
Avg EPS beat(4)0.65%
Min EPS beat(4)-2.82%
Max EPS beat(4)4.72%
EPS beat(8)5
Avg EPS beat(8)1.41%
EPS beat(12)9
Avg EPS beat(12)6.22%
EPS beat(16)11
Avg EPS beat(16)4.73%
Revenue beat(2)1
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-4.93%
Max Revenue beat(4)2.63%
Revenue beat(8)3
Avg Revenue beat(8)-1.19%
Revenue beat(12)7
Avg Revenue beat(12)1.99%
Revenue beat(16)9
Avg Revenue beat(16)1.58%
PT rev (1m)0%
PT rev (3m)-17.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.57%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)-7.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.11%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)9.51%
Valuation
Industry RankSector Rank
PE 7.29
Fwd PE 8.28
P/S 4.3
P/FCF 9.61
P/OCF 9.61
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)1.88
EY13.71%
EPS(NY)1.66
Fwd EY12.07%
FCF(TTM)1.43
FCFY10.41%
OCF(TTM)1.43
OCFY10.41%
SpS3.19
BVpS12.41
TBVpS12.41
PEG (NY)N/A
PEG (5Y)3.25
Profitability
Industry RankSector Rank
ROA 4.41%
ROE 9.39%
ROCE 5.61%
ROIC 4.43%
ROICexc 4.57%
ROICexgc 4.57%
OM 45.14%
PM (TTM) 36.54%
GM 48.37%
FCFM 44.71%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.36%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
ROICexc(3y)4.5%
ROICexc(5y)4.19%
ROICexgc(3y)4.5%
ROICexgc(5y)4.19%
ROCE(3y)5.54%
ROCE(5y)5.14%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y2.42%
ROICexc growth 3Y8.12%
ROICexc growth 5Y2.4%
OM growth 3Y-3.83%
OM growth 5Y-1.49%
PM growth 3Y-26.4%
PM growth 5Y5.7%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 9.24
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.64
Cash Conversion N/A
Profit Quality 122.35%
Current Ratio 2.28
Quick Ratio 2.28
Altman-Z 0.81
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)133.19%
Profit Quality(5y)1416.48%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.74%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.64%
EPS Next Y-18.46%
EPS Next 2Y-9.02%
EPS Next 3Y-5.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.02%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%-12.67%
Revenue Next Year12.63%
Revenue Next 2Y9.25%
Revenue Next 3Y6.47%
Revenue Next 5YN/A
EBIT growth 1Y-4.52%
EBIT growth 3Y6.51%
EBIT growth 5Y-0.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.98%
FCF growth 3Y11.32%
FCF growth 5YN/A
OCF growth 1Y-54.98%
OCF growth 3Y11.32%
OCF growth 5YN/A